Your browser doesn't support javascript.
loading
One-Year Follow-Up of Advanced Hybrid Closed-Loop System in Adults with Type 1 Diabetes Previously Naive to Diabetes Technology: The Effect of Switching to a Calibration-Free Sensor.
Matejko, Bartlomiej; Juza, Anna; Kiec-Wilk, Beata; Cyranka, Katarzyna; Krzyzowska, Sabina; Cohen, Ohad; Malecki, Maciej T; Klupa, Tomasz.
Afiliação
  • Matejko B; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Juza A; Department of Metabolic Diseases and Diabetology, University Hospital in Krakow, Krakow, Poland.
  • Kiec-Wilk B; Department of Internal Medicine, Clinical Provincial Hospital of Frederic Chopin No. 1 in Rzeszów, Rzeszów, Poland.
  • Cyranka K; Department of Internal Medicine, College of Medical Sciences, University of Rzeszów, Rzeszów, Poland.
  • Krzyzowska S; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Cohen O; Department of Metabolic Diseases and Diabetology, University Hospital in Krakow, Krakow, Poland.
  • Malecki MT; Department of Metabolic Diseases, Jagiellonian University Medical College, Krakow, Poland.
  • Klupa T; Department of Metabolic Diseases and Diabetology, University Hospital in Krakow, Krakow, Poland.
Diabetes Technol Ther ; 25(8): 554-558, 2023 08.
Article em En | MEDLINE | ID: mdl-37184526
The aim of this study was to observe the 1-year clinical outcomes of people with type 1 diabetes who switched from multiple daily injection + blood glucose meter to an advanced hybrid closed-loop (AHCL) system (Medtronic MiniMed™ 780G system [MM 780G]). In addition, the effect of changing at month 6 to a calibration-free sensor (Guardian™ 4 Sensor [G4S]) was evaluated. Eighteen participants (10 men, age 40.9 ± 7.6 years) completed 1 year of MM 780G use. Time in range (TIR; 70-180 mg/dL) remained stable and ranged from 83.2% in month 9 to 84.8% in month 3. There was no difference between TIR at 3 months before switching versus 3 months after switching to G4S (P = 0.614). AHCL system in adults significantly improves glycemic outcomes. This improved glycemic control was maintained over the 12 months. Switching to a calibration-free sensor (G4S) did not affect outcomes but required less patient involvement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Diabetes Technol Ther Assunto da revista: ENDOCRINOLOGIA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Revista: Diabetes Technol Ther Assunto da revista: ENDOCRINOLOGIA / TERAPEUTICA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia País de publicação: Estados Unidos